Patents by Inventor Kirandeep Kaur

Kirandeep Kaur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-morpholinyl-2-pyrazolyl-9H-purine derivatives and their use as PI3K inhibitors
    Patent number: 10174035
    Abstract: The present invention relates to a pyrazole derivative of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof, a hydrate thereof, stereoisomer thereof or a deuterium form thereof, wherein, n, Y, Ra, R1, R2, R3, R4, R5 and R6 are as defined hereinafter in the specification, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) as inhibitors of phosphatidylinositol-3-kinase (PI3K), which can be used for treating or preventing inflammatory, autoimmune, orphan and hyperproliferative disease and disorder.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: January 8, 2019
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Kirandeep Kaur Samby, Yogesh Baban Surase, Sagar Ramdas Amale, Suresh Kumar Gorla, Priyanka Patel, Ashwani Kumar Verma
  • 6-MORPHOLINYL-2-PYRAZOLYL-9H-PURINE DERIVATIVES AND THEIR USE AS PI3K INHIBITORS
    Publication number: 20180072732
    Abstract: The present invention relates to a pyrazole derivative of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof, a hydrate thereof, stereoisomer thereof or a deuterium form thereof, wherein, n, Y, Ra, R1, R2, R3, R4, R5 and R6 are as defined hereinafter in the specification, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) as inhibitors of phosphatidylinositol-3-kinase (PI3K), which can be used for treating or preventing inflammatory, autoimmune, orphan and hyperproliferative disease and disorder.
    Type: Application
    Filed: March 29, 2016
    Publication date: March 15, 2018
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Kirandeep Kaur Samby, Yogesh Baban Surase, Sagar Ramdas Amale, Suresh Kumar Gorla, Priyanka Patel, Ashwani Kumar Verma
  • MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20100056496
    Abstract: The present invention generally relates to muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The present invention also relates to processes for preparing compounds described herein, pharmaceutical compositions thereof, and methods for treating diseases mediated through muscarinic receptors. Formula (I) or a pharmaceutically accepted salt, pharmaceutically acceptable solvate, enantiomers, diastereomer, polymorph or N-oxide thereof, wherein X is.
    Type: Application
    Filed: September 4, 2007
    Publication date: March 4, 2010
    Inventors: Naresh Kumar, Kirandeep Kaur, Yogesh D. Shejul, Abhijit Ray, Suman Gupta, Shivani Malhotra, Rajkumar Shirumalla
  • AZABICYCLIC MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20100016400
    Abstract: The present invention generally relates to muscarinic receptor antagonists, which are useful for treating various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to processes for preparing compounds described herein, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: November 18, 2005
    Publication date: January 21, 2010
    Inventors: Naresh Kumar, Mohammad Salman, Kirandeep Kaur, Anita Mehta, Sudershan K. Arora, Anita Chugh
  • MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20090137623
    Abstract: The present invention relates to muscarinic receptor modulators, specifically, 7-oxo-2-azabicyclo[2.2.1]heptanes of formula (I) which are useful for the treatment of various diseases and conditions, for example, Alzheimer's disease, glaucoma, psychosis, particularly schizophrenia or schizophreniform conditions, mania, pain, bipolar disorder, depression, sleeping disorders, epilepsy, gastrointestinal motility disorders, urinary incontinence, and cognition enhancement.
    Type: Application
    Filed: January 2, 2007
    Publication date: May 28, 2009
    Inventors: Naresh Kumar, Ian Anthony Cliffe, Mohammad Salman, Venkata P. Palle, Kirandeep Kaur, Yogesh D. Shejul, Anita Chugh, Suman Gupta, Abhijit Ray, Shivani Malhotra, Raj Kumar Shirumalla
  • 3-AZABICYCLOOCTANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20090131410
    Abstract: Provided are muscarinic receptor antagonists, which can be useful in treating various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. Also provided are processes for preparing compounds described herein, pharmaceutical compositions thereof, and methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: October 5, 2006
    Publication date: May 21, 2009
    Inventors: Naresh Kumar, Kirandeep Kaur, Suman Gupta, Anita Chugh, Mohammad Salman, Raj Kumar Shirumalla, Shivani Malhotra
  • MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20090105221
    Abstract: This present invention generally relates to muscarinic receptor antagonists of Formula (I), which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the prepration of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: September 28, 2005
    Publication date: April 23, 2009
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Mohammad Salman, Pakala Kumara Savithru Sarma, Arani Pal, Anita Chugh, Suman Gupta, Venkata P. Palle, Naresh Kumar, Kirandeep Kaur
  • Muscarinic Receptor Antagonists
    Publication number: 20090012116
    Abstract: Provided are muscarinic receptor antagonists, which can be useful in treating various diseases of the respiratory, urinary or gastrointestinal system mediated through muscarinic receptors. Also provided are processes for preparing compounds described herein, pharmaceutical compositions comprising compounds described herein, and methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: July 11, 2006
    Publication date: January 8, 2009
    Inventors: Naresh Kumar, Kirandeep Kaur, Sandeep Sinha, Suman Gupta, Venkata P. Palle, Anita Chugh
  • 3,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor Antagonists
    Publication number: 20080319043
    Abstract: The present invention generally relates to muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: May 1, 2006
    Publication date: December 25, 2008
    Inventors: Mohammad Salman, Naresh Kumar, Kirandeep Kaur, Shelly Aeron, Pakala Kumara Savithru Sarma, Sankaranarayanan Dharmarajan, Anita Mehta, Anita Chugh
  • Azabicyclo derivatives as muscarinic receptor antagonists
    Patent number: 7446123
    Abstract: This invention generally relates to muscarinic receptor antagonists of formula (I) which are useful, among other uses for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
    Type: Grant
    Filed: January 7, 2004
    Date of Patent: November 4, 2008
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Mohammad Salman, Anita Mehta, Pakala Kumara Savithru Sarma, Naresh Kumar, Sankaranarayanan Dharmarajan, Kirandeep Kaur, Anita Chugh
  • Muscarinic Receptor Antagonists
    Publication number: 20080255188
    Abstract: This present invention generally relates to muscarinic receptor antagonists of Formula (I), which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: July 11, 2006
    Publication date: October 16, 2008
    Inventors: Naresh Kumar, Mohammad Salman, Kirandeep Kaur, Anita Chugh, Sandeep Sinha
  • 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
    Patent number: 7265147
    Abstract: This invention generally relates to the derivatives of 3,6 disubstituted azabicyclo[3.1.0]hexanes. The compounds of this invention are muscarinic receptor antagonists which are useful, inter-alia, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods for treating the diseases mediated through muscarinic receptors.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: September 4, 2007
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Anita Mehta, Arundutt V. Silamkoti, Kirandeep Kaur, Jang Bahadur Gupta
  • Azabicyclo Derivatives as Muscarinic Receptor Antagonists
    Publication number: 20060287380
    Abstract: This invention generally relates to muscarinic receptor antagonists of formula (I) which are useful, among other uses for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
    Type: Application
    Filed: January 7, 2004
    Publication date: December 21, 2006
    Inventors: Mohammad Salman, Anita Mehta, Pakata Sarma, Naresh Kumar, Sankaranarayanan Dharmarajan, Kirandeep Kaur, Anita Chugh
  • 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
    Publication number: 20060122253
    Abstract: This invention generally relates to the derivatives of 3,6 disubstituted azabicyclo[3.1.0]hexanes. The compounds of this invention are muscarinic receptor antagonists which are useful, inter-alia, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods for treating the diseases mediated through muscarinic receptors.
    Type: Application
    Filed: July 31, 2002
    Publication date: June 8, 2006
    Inventors: Anita Mehta, Arundutt Silamkoti, Kirandeep Kaur, Jang Gupta